InMedica Development Corporation - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for InMedica Development Corporation. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

InMedica Development Corporation. The Group's principal activities is to develop and sale of medical technology. It develops and markets portable electrocardiograph (ECG) monitor. Other activity is to research and develop a device to measure hematocrit technology. The hematocrit is the percentage of red blood cells in a given volume of blood. It entered into a Development, Licensing and Manufacturing agreement with Chi Lin pursuant to which InMedica granted Chi Lin a worldwide license to develop and manufacture products based on the hematocrit technology. The Group operates throughout the United States. On 12-Dec-2008, the Group acquired ValuMobile, LLC.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report